Author

Shan Zhao

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Aldosterone-mineralocorticoid receptor signaling and residual cardiorenal risk in type 2 diabetes.

Overall, MR signaling is best regarded as a biologically plausible contributor within a multifactorial residual-risk model; prospective validation is required before biomarker-guided MR-targeted therapy can be recommended.

Shan Zhao, C. Wang, Yang Ou · Acta Diabetologica · 0 citations